Vericel Aktie

Vericel für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A12FU4 / ISIN: US92346J1088

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
06.11.2025 17:41:26

Vericel Stock Gains 8% On Quarter Results

(RTTNews) - Vericel Corporation (VCEL) rose 8.08% to $40.21, up $3.01, after reporting a record third quarter for 2025. The company delivered revenue of $67.5 million, up from $57.9 million a year ago, and a net income of $5.1 million, or $0.10 EPS, reversing last year's loss of $0.9 million.

The company's MACI product line led growth with a 25 percent increase in revenue to $55.7 million, gross margin expanded to 73.5 percent, adjusted EBITDA rose to $17.0 million, 25 percent of revenue, and operating cash flow hit a record $22.1 million.

Vericel reaffirmed full-year guidance of $272-$276 million in revenue and a target gross margin of approximately 74 percent.

On the announcement day, VCEL's trading volume surged above average as the market reacted to both the revenue beat and profitability turn. The stock's 52-week range is approximately $29.24 - $63.00.

Analysen zu Vericel Corpmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Vericel Corp 32,00 0,00% Vericel Corp